Inhibition of platelet aggregation in vitro and ex vivo by the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-l,2,3,4-tetrahydro-9-carbazolepropanoic acid - Seuter, F; Perzborn, E; Rosentreter, U; Böshagen, H; Fiedler, V B (Arzneimittelforschung, 1989)